
Company valuation, historical trends, and peer comparisons.
According to Johnson & Johnson’s latest financial reports and current stock price. The company's current Enterprise Value is 692.93B. This represents a change of 10.37% compared to the average of 627.82B of the last 4 quarters.
The mean historical Enterprise Value of Johnson & Johnson over the last ten years is 414.83B. The current 692.93B Enterprise Value has changed 67.04% with respect to the historical average. Over the past ten years (40 quarters), JNJ's Enterprise Value was at its highest in in the September 2026 quarter at 693.35B. The Enterprise Value was at its lowest in in the December 2016 quarter at 319.97B.
Average
414.83B
Median
399.48B
Minimum
319.97B
Maximum
532.30B
Discovering the peaks and valleys of Johnson & Johnson Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 48.86%
Maximum Annual Enterprise Value = 532.30B
Minimum Annual Increase = -17.17%
Minimum Annual Enterprise Value = 319.97B
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 532.30B | 48.86% |
| 2024 | 357.59B | -11.61% |
| 2023 | 404.57B | -17.17% |
| 2023 | 488.44B | 3.87% |
| 2022 | 470.24B | 8.53% |
| 2021 | 433.27B | 9.86% |
| 2019 | 394.39B | 10.80% |
| 2018 | 355.95B | -9.10% |
| 2017 | 391.56B | 22.37% |
| 2016 | 319.97B | 10.66% |
The current Enterprise Value of Johnson & Johnson (JNJ) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
431.49B
5-year avg
450.63B
10-year avg
414.83B
Johnson & Johnson’s Enterprise Value is greater than Merck & Co., Inc. (415.14B), greater than AstraZeneca PLC (318.97B), greater than Pfizer Inc. (236.34B), greater than Novartis AG (350.04B), greater than GSK plc (96.50B), greater than Sanofi (117.98B), greater than Amgen Inc. (299.50B), greater than AbbVie Inc. (591.13B), greater than Bristol-Myers Squibb Company (166.45B), greater than Gilead Sciences, Inc. (236.14B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 415.14B | $370.91B | |
| 318.97B | $293.13B | |
| 236.34B | $175.49B | |
| 350.04B | $311.59B | |
| 96.50B | $103.68B | |
| 117.98B | $113.74B | |
| 299.50B | $258.68B | |
| 591.13B | $521.00B | |
| 166.45B | $131.21B | |
| 236.14B | $216.35B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Johnson & Johnson using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Johnson & Johnson or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Johnson & Johnson's Enterprise Value?
What is the highest Enterprise Value for Johnson & Johnson (JNJ)?
What is the 3-year average Enterprise Value for Johnson & Johnson (JNJ)?
What is the 5-year average Enterprise Value for Johnson & Johnson (JNJ)?
How does the current Enterprise Value for Johnson & Johnson (JNJ) compare to its historical average?